Is HR a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Occupancy and leasing momentum, with revenue (ttm) at ~$1.2B. The bear case rests on as a REIT, HR is sensitive to interest rates, since higher rates raise borrowing costs and can compress the price investors pay for its cash flows. Analysts covering it are spread from $18.00 to $24.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. As a REIT, HR is sensitive to interest rates, since higher rates raise borrowing costs and can compress the price investors pay for its cash flows. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $18.00, -17.5% from the $21.82 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Occupancy and leasing momentum. HR reported record quarterly leasing of more than 2 million square feet in Q1 2026 and same-store occupancy of about 92.3 percent, up roughly 110 basis points year over year. The most optimistic analyst target on HR is $24.00, +10.0% from the $21.82 price. That figure is only reachable if this thesis works close to its best case.

As a REIT, HR is sensitive to interest rates, since higher rates raise borrowing costs and can compress the price investors pay for its cash flows. Its FFO payout leaves limited cushion, and the dividend has been trimmed in the past, so distribution coverage is worth watching. Integration of the large Healthcare Trust of America portfolio, tenant credit and move-outs, and elevated leverage relative to some peers add execution risk. Asset sales used to cut debt can also dilute near-term earnings power. Any broader weakness in commercial real estate values could weigh on the shares. The most pessimistic published target is $18.00, -17.5% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Healthcare Realty Trust is a real estate investment trust focused on outpatient medical facilities, primarily medical office buildings leased to health systems, physician groups, a

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Occupancy and leasing momentum) stalling in the reported numbers rather than in the narrative, the risk above (as a REIT, HR is sensitive to interest rates, since higher rates raise borrowing costs and can compress the price investors pay for its cash flows) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

It is a REIT that owns and operates outpatient medical facilities, mainly medical office buildings leased to health systems and physician groups, with properties concentrated near acute-care hospital campuses. It collects rent from these healthcare tenants.

HR pays a quarterly dividend, roughly $0.24 per share, for a yield in the mid-4-percent range as of mid-2026. Whether that suits a given investor depends on their income goals and risk tolerance; note the dividend has been reduced in the past when cash flow tightened.

In Q1 2026 HR reported normalized FFO of about $0.41 per share, same-store cash NOI growth near 6.9 percent, occupancy around 92.3 percent, and record leasing of more than 2 million square feet, and it raised full-year FFO guidance.